Incidence of breakthrough COVID-19 in patients with hematological disorders who received pre-exposure prophylaxis with tixagevimab-cilgavimab: a retrospective study in Japan - Top-Institutions - MDSpire

Incidence of breakthrough COVID-19 in patients with hematological disorders who received pre-exposure prophylaxis with tixagevimab-cilgavimab: a retrospective study in Japan

  • By

  • Mizuki Haraguchi

  • Hisashi Yamamoto

  • Otoya Watanabe

  • Takashi Sakoh

  • Keiko Ishida

  • Sho Ogura

  • Masayo Katoh-Morishima

  • Yuki Taya

  • Aya Nishida

  • Daisuke Kaji

  • Shinsuke Takagi

  • Go Yamamoto

  • Naoyuki Uchida

  • Hideki Araoka

  • June 17, 2023

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Infectious Diseases
    • Immunology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology
    • Oncology
    • Infectious Diseases

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Immunology
    • Infectious Diseases

  • #4

    National Cancer Center Hospital
    National Cancer Center Hospital

    Tokyo, Tokyo

    Key Differentiators

    • Hematology
    • Infectious Diseases
    • Clinical Research

  • #5

    Toranomon Hospital
    Toranomon Hospital

    Tokyo, Tokyo

    Key Differentiators

    • Hematology
    • Infectious Diseases

Original Source(s)

Incidence of breakthrough COVID-19 in patients with hematological disorders who received pre-exposure prophylaxis with tixagevimab-cilgavimab: a retrospective study in Japan

  • by Mizuki Haraguchi, Hisashi Yamamoto, Otoya Watanabe, Takashi Sakoh, Keiko Ishida, Sho Ogura, Masayo Katoh-Morishima, Yuki Taya, Aya Nishida, Daisuke Kaji, Shinsuke Takagi, Go Yamamoto, Naoyuki Uchida, Hideki Araoka

  • June 17, 2023

Related Content

Normalization of Seasonality and Age Distribution of Pediatric RSV Infection Following the Pandemic Disruption in the Netherlands

Utilizing AI-Enhanced Chest X-Rays and Hematological Indicators to Forecast Mortality and Intubation in COVID-19 Patients at a Secondary Referral Hospital in Indonesia

Mendelian Randomization and Infection: Pitfalls and Promises